본문으로 건너뛰기
← 뒤로

Superficial Anaplastic Lymphoma Kinase ()-Rearranged Myxoid Spindle Cell Neoplasms: A Case Report and Literature Review.

증례보고 1/5 보강
International journal of surgical pathology 📖 저널 OA 9.7% 2022: 1/3 OA 2023: 2/4 OA 2024: 1/2 OA 2025: 1/8 OA 2026: 5/80 OA 2022~2026 2026 Vol.34(2) p. 461-468
Retraction 확인
출처

Grosse C, Grosse A

ℹ️ 이 논문은 무료 전문이 아직 없습니다. 코퍼스 전체의 43.9%는 무료 가능 (통계 →) · 🏥 기관 EZproxy로 시도

📝 환자 설명용 한 줄

Anaplastic lymphoma kinase ()-rearranged myxoid spindle cell tumors represent a recently recognized subgroup of kinase fusion-positive mesenchymal neoplasms.

이 논문을 인용하기

↓ .bib ↓ .ris
APA Grosse C, Grosse A (2026). Superficial Anaplastic Lymphoma Kinase ()-Rearranged Myxoid Spindle Cell Neoplasms: A Case Report and Literature Review.. International journal of surgical pathology, 34(2), 461-468. https://doi.org/10.1177/10668969251370306
MLA Grosse C, et al.. "Superficial Anaplastic Lymphoma Kinase ()-Rearranged Myxoid Spindle Cell Neoplasms: A Case Report and Literature Review.." International journal of surgical pathology, vol. 34, no. 2, 2026, pp. 461-468.
PMID 40905721 ↗

Abstract

Anaplastic lymphoma kinase ()-rearranged myxoid spindle cell tumors represent a recently recognized subgroup of kinase fusion-positive mesenchymal neoplasms. These tumors often arise in the superficial soft tissues but may occasionally be found in deeper tissues, or, rarely, within visceral organs. The term (SAMS) comprises a distinct subset of cutaneous soft tissue tumors with superficial location and spindle cell morphology, exhibiting bland cytomorphology and favorable clinical outcomes. -rearranged mesenchymal tumors with high-grade histologic features have been described, but their relationship to SAMS is unclear. Immunohistochemically, SAMS express ALK, CD34 and frequently S100. On the molecular level, they classically harbor gene rearrangements. While fusions are encountered in a variety of neoplastic entities, including inflammatory myofibroblastic tumors and epithelioid fibrous histiocytomas, SAMS are distinct in both morphology and immunophenotype. Since the initial description of SAMS by Dermawan et al in 2021, several single reports and series have been reported, expanding the clinicopathologic and molecular spectrum and highlighting the clinical and morphological heterogeneity within the group of -rearranged mesenchymal tumors.

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반